Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Besser

Showing results (391-400 of 828) with videos related to

Pageof 83
Sort By:
Nuclear Medicine Communications|August 1, 1989
Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomasA J Sinclair, J Bomanji, P Harris, et al.
British Medical Journal|December 14, 1974
Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunctionC H Mortimer, A S McNeilly, R A Fisher, et al.
The Journal of Endocrinology|May 1, 1979
Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings]G Delitala, W A Stubbs, T Yeo, et al.
Clinical Endocrinology|September 1, 1985
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomasR J Ross, A Grossman, P Bouloux, et al.
Acta Paediatrica Scandinavica|May 1, 1989
Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasiaA A Leaf, R J Ross, R B Jones, et al.
Metabolism: Clinical and Experimental|September 1, 1992
Gallstones during octreotide therapyR H Dowling, S H Hussaini, G M Murphy, et al.
Clinical Endocrinology|November 1, 1994
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndromeJ M Kirk, D B Grant, M O Savage, et al.
Nuclear Medicine Communications|October 1, 1993
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidineJ Bomanji, K E Britton, E Ur, et al.
Clinical Endocrinology|July 1, 1994
Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadismJ M Kirk, M O Savage, D B Grant, et al.
The British Journal of Dermatology|March 1, 1983
Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgarisC R Darley, J W Moore, G M Besser, et al.
Pageof 83

Showing results (391-400 of 828) with videos related to

Sort By:
Pageof 83
Nuclear Medicine Communications|August 1, 1989
Pre- and post-treatment distribution pattern of 123I-MIBG in patients with phaeochromocytomas and paragangliomasA J Sinclair, J Bomanji, P Harris, et al.
British Medical Journal|December 14, 1974
Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunctionC H Mortimer, A S McNeilly, R A Fisher, et al.
The Journal of Endocrinology|May 1, 1979
Action of dopamine receptor agonists and antagonists, and a serotonin antagonist on prolactin release from isolated rat pituitary cell columns [proceedings]G Delitala, W A Stubbs, T Yeo, et al.
Clinical Endocrinology|September 1, 1985
The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomasR J Ross, A Grossman, P Bouloux, et al.
Acta Paediatrica Scandinavica|May 1, 1989
Response to growth hormone-releasing hormone as evidence of hypothalamic defect in optic nerve hypoplasiaA A Leaf, R J Ross, R B Jones, et al.
Metabolism: Clinical and Experimental|September 1, 1992
Gallstones during octreotide therapyR H Dowling, S H Hussaini, G M Murphy, et al.
Clinical Endocrinology|November 1, 1994
Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndromeJ M Kirk, D B Grant, M O Savage, et al.
Nuclear Medicine Communications|October 1, 1993
Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidineJ Bomanji, K E Britton, E Ur, et al.
Clinical Endocrinology|July 1, 1994
Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadismJ M Kirk, M O Savage, D B Grant, et al.
The British Journal of Dermatology|March 1, 1983
Low dose prednisolone or oestrogen in the treatment of women with late onset or persistent acne vulgarisC R Darley, J W Moore, G M Besser, et al.
Pageof 83